0001104659-15-066590.txt : 20150923
0001104659-15-066590.hdr.sgml : 20150923
20150923060055
ACCESSION NUMBER: 0001104659-15-066590
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150918
FILED AS OF DATE: 20150923
DATE AS OF CHANGE: 20150923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001436304
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 818-587-4500
MAIL ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smither John W
CENTRAL INDEX KEY: 0001559583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35663
FILM NUMBER: 151120287
MAIL ADDRESS:
STREET 1: C/O KYTHERA BIOPHARMACEUTICALS, INC.
STREET 2: 27200 WEST AGOURA ROAD, SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
4
1
a4.xml
4
X0306
4
2015-09-18
0
0001436304
KYTHERA BIOPHARMACEUTICALS INC
KYTH
0001559583
Smither John W
C/O KYTHERA BIOPHARMACEUTICALS, INC.
30930 RUSSELL RANCH ROAD, 3RD FLOOR
WESTLAKE VILLAGE
CA
91362
0
1
0
0
Chief Financial Officer
Common Stock
2015-09-18
4
M
0
1054
8.22
A
4422
D
Common Stock
2015-09-18
4
S
0
1054
74.95
D
3368
D
Common Stock
2015-09-22
4
M
0
3476
8.22
A
6844
D
Common Stock
2015-09-22
4
S
0
3476
74.9
D
3368
D
Common Stock
2015-09-22
4
M
0
2115
8.22
A
5483
D
Common Stock
2015-09-22
4
S
0
2115
74.9
D
3368
D
Common Stock
2015-06-26
5
G
0
E
1400
0
D
6216
I
See footnote
Stock Options
8.22
2015-09-18
4
M
0
1054
0
D
2022-02-01
Common Stock
1054
4328
D
Stock Options
8.22
2015-09-22
4
M
0
3476
0
D
2022-02-01
Common Stock
3476
852
D
Stock Options
8.22
2015-09-22
4
M
0
2115
0
D
2022-02-01
Common Stock
2115
13272
D
Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006. John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust").
25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.
/s/ Keith Klein, as Attorney-in-Fact for John W. Smither
2015-09-22